Rakesh Kumar
Indian Institute of Technology Kanpur · 194 works · 6,678 citations · h-index 41
Top works
- Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic BRAF by the Kinase Inhibitor SB-590885
- Studies on Diamagnetic Susceptibility of Biologically Active Heterocycles, Part 2 Diamagnetic Susceptibilities of 4H-1,4-Benzothiazines and their Sulfones
- Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
- Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1 H -indol-5-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
- Experimental and theoretical studies on diamagnetic susceptibility of amides and their N-substituted derivatives
- Discovery of 5-[[4-[(2,3-Dimethyl-2 H -indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor
- Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
- Regulation of Microfilament Reorganization and Invasiveness of Breast Cancer Cells by Kinase Dead p21-activated Kinase-1
- Association Between Pak1 Expression and Subcellular Localization and Tamoxifen Resistance in Breast Cancer Patients
- p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells
- The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma
- Regional Flood Frequency Analysis Using L-Moments for North Brahmaputra Region of India
- AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines
- Development of Regional Flood Frequency Relationships Using L-moments for Middle Ganga Plains Subzone 1(f) of India
- Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion
- Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development
- Synthesis of 6-trifluoromethyl-4h-1,4-benzothiazines as possible anticancer agents
- Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer
- Complexes of dichlorobis(halosulphato)titanium(IV) with pyridine, quinoline, dimethyl sulphoxide and acetylacetone
- Regional Flood Formulas for Seven Subzones of Zone 3 of India